Exploring patient-specific mechanisms in SYNGAP1-related pathology to develop targeted therapeutic strategies
Bernadette Basilico, Chiara D'Antoni, Mattia Miotto, Davide Ragozzino, Jessica Rosati, Silvia Di Angelantonio · FENS Forum 2024
Mutations in SYNGAP1 gene represent one of the most frequent genetic causes of neurodevelopmental disorders. De novo heterozygous SYNGAP1 variants are associated with a complex clinical presentation, characterized by intellectual disability, epileptic encephalopathy, hyperactivity, sleep and language disorder, and autism spectrum disorder. The SynGAP protein is highly expressed in excitatory neurons and localized mainly to synapses as a core post-synaptic density protein. Here, it acts as a potent regulator of the RAS/ERK signalling pathway, regulating synaptic plasticity and neuronal homeosta
ePoster · Neuroscience